CYCLACEL PHARMACEUTICALS, INC. (CYCC) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.
The information set forth under this Item 2.02. Results of
Operations and Financial Condition, including the exhibit
attached hereto, shall not be deemed filed for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended,
nor shall it be deemed incorporated by reference into any filing
under the Securities Act of 1933, as amended, except as shall be
expressly set forth by specific reference in such filing.
Attached as Exhibit 99.1 is a copy of a press release of Cyclacel
Pharmaceuticals, Inc. (the Company), dated
November 14, 2016, announcing certain financial results for the
third quarter ended September 30, 2016.
The Company will conduct a conference call to review its
financial results on November 14, 2016, at 4:30 p.m., Eastern
Time.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit Number | Description | |
| 99.1 |
Press release announcing financial results for the third quarter ended September 30, 2016, dated November 14, 2016. |
About CYCLACEL PHARMACEUTICALS, INC. (CYCC)
